Higher Adherence to Treatment With Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin Because of Side Effects in Cancer-Associated Venous Thromboembolism
暂无分享,去创建一个
D. Jiménez | M. Huisman | S. Cannegieter | P. D. den Exter | R. Morillo | D. Barrios | F. A. Klok | S. J. van der Wall